Altered regions included known targets, such as CDK4 (cyclin-dependent kinase 4) and SAS (sarcoma amplified sequence), as well as MDM2 (mouse double minute 2 homolog), for 12q14.1 and 12q15 amplifications, respectively. Here, CDK4 is linked to sarcoma.